Welcome to our dedicated page for BOWHEAD SPECIALTY HLDGS news (Ticker: BOW), a resource for investors and traders seeking the latest updates and insights on BOWHEAD SPECIALTY HLDGS stock.
Bowhead Specialty Holdings Inc (NYSE: BOW) delivers specialized commercial insurance solutions through expert underwriting across casualty, healthcare liability, and niche risk markets. This news hub provides investors with essential updates on corporate developments shaping the company's position in the property & casualty insurance sector.
Access real-time announcements including earnings reports, strategic partnerships, leadership changes, and regulatory filings. Our curated collection features press releases on underwriting innovations, claims management advancements, and market expansion initiatives within key industries like construction and healthcare.
Key updates include:
- Financial performance disclosures
- Mergers & acquisitions activity
- Product line expansions
- Industry conference participation
- Regulatory compliance developments
Bookmark this page for streamlined tracking of BOW's operational milestones and strategic decisions directly impacting its specialty insurance market leadership.
Bowhead Specialty (NYSE:BOW) has announced a secondary public offering of 2,000,000 shares of its common stock by GPC Partners Investments (SPV III) LP. The offering will be underwritten by RBC Capital Markets, which will sell the shares through negotiated transactions or at prevailing market prices.
Notably, Bowhead Specialty will not receive any proceeds from this secondary offering as the company itself is not selling any shares. The offering will be conducted through an effective registration statement and prospectus filed with the SEC under Form S-3 (File No. 333-287860), which became effective on June 18, 2025.
Bowhead Specialty Holdings (NYSE:BOW) reported strong Q2 2025 financial results, with gross written premiums increasing 32.4% to $232.4 million. The company achieved net income of $12.3 million ($0.36 per diluted share) and adjusted net income of $12.8 million ($0.37 per diluted share).
Key performance metrics include a return on equity of 12.4%, improved combined ratio of 96.8% (down from 99.3% in Q2 2024), and a 55.8% increase in net investment income to $13.7 million. Growth was observed across all divisions, with Casualty leading at 31.9% growth to $150.7 million, Professional Liability up 23.3% to $54.8 million, and Healthcare Liability rising 39.0% to $23.5 million.
Bowhead Specialty (NYSE:BOW) has scheduled its second quarter 2025 earnings release and conference call. The company will release its financial results on August 5, 2025, at 7:00 a.m. ET before market open. A conference call to discuss the results will follow at 8:30 a.m. ET on the same day.
The earnings materials will be accessible through the company's Investor Relations website. Investors can participate via a live webcast or through a dial-in option for listen-only mode. The webcast replay will remain available for one year after the call.
Bowhead Specialty Holdings (NYSE: BOW) has scheduled its first quarter 2025 earnings release for Tuesday, May 6, 2025. The financial results will be published at approximately 7:00 a.m. Eastern Time before market opening.
The company will host a conference call to discuss the results at 8:30 a.m. Eastern Time on the same day. Investors can access the call through a live webcast on Bowhead's Investor Relations website, with a listen-only dial-in option available after registration. Participants are advised to join at least 10 minutes before the call starts. The webcast replay will be accessible on the company's IR website for one year following the event.
Bowhead Specialty Holdings (NYSE: BOW) announced its Q4 2024 financial results. Gross written premiums rose 26.3% to $184.8 million. Net income was $13.6 million, or $0.41 per diluted share, while adjusted net income was $14.1 million, or $0.42 per diluted share. The return on equity was 14.8%, and adjusted return on equity was 15.3%. Book value per share stood at $11.34, and diluted book value per share was $11.03.
For the full year 2024, gross written premiums increased 37.0% to $695.7 million. Net income reached $38.2 million, or $1.29 per diluted share, with adjusted net income at $42.7 million, or $1.44 per diluted share. The return on equity was 13.6%, and adjusted return on equity was 15.2%.
The Casualty division led growth with a 56% increase in premiums. The Healthcare Liability and Professional Liability divisions also saw double-digit growth. Bowhead launched Baleen, a tech-enabled underwriting operation, which generated $1.2 million in gross written premiums in Q4, a 175% sequential growth.
The loss ratio for 2024 was 64.4%, up from 63.0% in 2023. The expense ratio decreased to 31.4% for the year. Net investment income surged 107.1% to $40.1 million, with a book yield of 4.6% and a new money rate of 4.9%.
Bowhead Specialty Holdings (NYSE: BOW) has scheduled its Q4 2024 earnings release for February 25, 2025, before market opens at 7:00 a.m. ET. The company will host a conference call to discuss results at 8:30 a.m. ET on the same day.
Management will participate in two upcoming investor conferences: The 2025 AIFA Conference in Naples, Florida (March 2-4), where CEO Stephen Sills will join a panel discussion on March 3 at 3:15 p.m. ET, and the 2025 RBC Capital Markets Global Financial Institutions Conference in New York on March 5. At both events, management will be available for one-on-one and small group meetings.
Bowhead Specialty (NYSE: BOW) has announced its management team's participation in two upcoming investor conferences. At the Citizens JMP Financial Services Conference on November 12, 2024, in New York, CFO Brad Mulcahey and IR Head Shirley Yap will be available for meetings. On December 4, 2024, CEO Stephen Sills will join Mulcahey and Yap at Morgan Stanley's Virtual P&C Insurance Corporate Access Day for one-on-one and small group discussions. Event details and investor presentations are accessible on Bowhead's IR website.
Bowhead Specialty Holdings (NYSE: BOW) has announced the pricing of a secondary public offering of 4,000,000 shares of common stock by existing stockholders at $29.00 per share. The Selling Stockholders have granted underwriters a 30-day option to purchase up to 600,000 additional shares. The company will not receive any proceeds from the sale as it's not selling any shares. The offering is expected to close on October 25, 2024. J.P. Morgan, Morgan Stanley, and Keefe, Bruyette & Woods are acting as joint lead bookrunning managers.
Bowhead Specialty Holdings (NYSE: BOW) has announced a proposed underwritten secondary public offering of 4,000,000 shares of its common stock by certain stockholders. The Selling Stockholders may grant underwriters a 30-day option to purchase up to an additional 600,000 shares. Bowhead Specialty will not sell any shares or receive proceeds from this offering.
J.P. Morgan, Morgan Stanley, and Keefe, Bruyette & Woods are acting as joint lead bookrunning managers. The offering is subject to market conditions and will be made only through a prospectus. A registration statement has been filed with the SEC but is not yet effective. This press release does not constitute an offer to sell or solicitation of an offer to buy these securities.